Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels

被引:137
作者
Jones, S
Holmes, CJ
Krediet, RT
Mackenzie, R
Faict, D
Tranaeus, A
Williams, JD
Coles, GA
Topley, N
机构
[1] Univ Wales Coll Cardiff, Coll Med, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales
[2] Baxter Healthcare Corp, Div Renal, McGaw Pk, IL USA
[3] Univ Amsterdam, Acad Med Ctr, Dept Nephrol, NL-1105 AZ Amsterdam, Netherlands
[4] Baxter Healthcare Europe, Nivelles, Belgium
[5] Baxter Healthcare Corp, Renal Europe, Brussels, Belgium
关键词
dialysate; biocompatibility; effluent markers; peritoneal membrane integrity;
D O I
10.1046/j.1523-1755.2001.0590041529.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background In a randomized, controlled trial comparing a pH neutral, bicarbonate/lactate (B/L)-buffered PD solution to conventional acidic, lactate-buffered solution (C), the overnight dialysate levels of markers of inflammation/wound healing [hyaluronic acid (HA)], mesothelial cell mass/membrane integrity [cancer antigen 125 (CA125)], and fibrosis [transforming growth factor-beta1 (TGF-beta1) and procollagen I peptides (PICP)] were assessed over a six-month treatment period. Methods. One hundred six patients were randomized (2:1) to either the B/L group or C group. Overnight effluents were collected at entry into the study (time = 0 all patients on control solution) and then at three and six months after randomization. Aliquots were filtered, stored frozen, and assayed for HA, CA125, TGF-beta1, and PICP. Differences between groups were assessed by repeated-measures analysis of variance for unbalanced data using the SAS procedure MIXED. Results. In patients treated with B/L, there was a significant (P = 0.03) increase in CA125 after six months compared with time = 0 (19.76 +/- 11.8 vs. 24.4 +/- 13.8 U/mL; mean +/- SD; N = 51). In the same group of patients, HA levels were significantly decreased at both three and six months in the B/L-treated group (time = 0, 336.0 +/- 195.2; time = 3 months, 250.6 +/- 167.6; and time = 6 months, 290.5 +/- 224.6 ng/mL; mean +/- SD; P = 0.006, N = 47 and P = 0.003, N = 48, respectively). No significant changes in CA125 or HA levels were observed in the control group. There were no significant changes observed in the levels of PICP or TGF-beta1 in the B/L or C group over the six-month treatment period. Conclusions. These results suggest that continuous therapy with the B/L solutions modulates the levels of putative markers of peritoneal membrane integrity and inflammation. In the long term, this may positively impact the peritoneal membrane, Increasing its life as a dialyzing organ.
引用
收藏
页码:1529 / 1538
页数:10
相关论文
共 76 条
[1]   FIBROSIS LINKED TO TGF-BETA IN YET ANOTHER DISEASE [J].
BORDER, WA ;
NOBLE, NA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :655-656
[2]   PERITONEAL-DIALYSIS INDUCES A LOCAL STERILE INFLAMMATORY STATE AND THE MESOTHELIAL CELLS IN THE EFFLUENT ARE RELATED TO THE BACTERIAL PERITONITIS INCIDENCE [J].
BOS, HJ ;
STRUIJK, DG ;
TUK, CW ;
DEVELD, JC ;
HELMERHORST, TJM ;
HOEFSMIT, ECM ;
ARISZ, L ;
BEELEN, RHJ .
NEPHRON, 1991, 59 (03) :508-509
[3]  
Cappelli G, 1999, ADV PERIT D, V15, P238
[4]   ASSAY OF SERUM HYALURONIC-ACID IN CLINICAL-APPLICATION [J].
CHICHIBU, K ;
MATSUURA, T ;
SHICHIJO, S ;
YOKOYAMA, MM .
CLINICA CHIMICA ACTA, 1989, 181 (03) :317-323
[5]  
Coles GA, 1997, PERITON DIALYSIS INT, V17, P48
[6]   A controlled trial of two bicarbonate-containing dialysis fluids for CAPD -: Final report [J].
Coles, GA ;
O'Donoghue, DJ ;
Pritchard, N ;
Ogg, CS ;
Jani, FM ;
Gokal, R ;
Cancarini, GC ;
Maiorca, R ;
Tranæus, A ;
De Vos, C ;
Hopwood, A ;
Faict, D .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (12) :3165-3171
[7]  
Combet S, 2000, J AM SOC NEPHROL, V11, P717, DOI 10.1681/ASN.V114717
[8]  
Cooker LA, 1997, PERITON DIALYSIS INT, V17, P373
[9]   What really happens to people on long-term peritoneal dialysis? [J].
Davies, SJ ;
Phillips, L ;
Griffiths, AM ;
Russell, LH ;
Naish, PF ;
Russell, GI .
KIDNEY INTERNATIONAL, 1998, 54 (06) :2207-2217
[10]  
Davies SJ, 1996, NEPHROL DIAL TRANSPL, V11, P498